SCLC cell lines with a non-neuroendocrine phenotype were more sensitive to ferroptosis induction by GPX4 inhibition than SCLC cell lines with a more neuroendocrine subtype, which relied more on the thioredoxin antioxidant pathway 132. Here, GPX4 is linked to small cell lung carcinoma.